Trial intelligence / Profile preview

Pregabalin in HIV-associated neuropathic pain

NCT01049217Phase 3Terminated

Sponsor
Viatris
Start
Apr 2010
Primary completion
May 2012
Countries
9
01

Overview

A Phase 3 trial of pregabalin in neuropathic pain, HIV-associated distal symmetrical polyneuropathy (HIV-DSP), sponsored by Viatris. Started Apr 2010; status: terminated.

02

Drugs

pregabalin
03

Conditions

neuropathic painHIV-associated distal symmetrical polyneuropathy (HIV-DSP)

Beyond the preview

Go deeper on NCT01049217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01049217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call